Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
skin sensitisation: in vivo (LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
October- December 2003
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: The study was conducted accroding to OECD and GLP guidelines

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2004
Report date:
2004

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
GLP compliance:
yes (incl. QA statement)
Type of study:
mouse local lymph node assay (LLNA)

Test material

Constituent 1
Chemical structure
Reference substance name:
4-bromo-2,6-difluorobenzoic acid
EC Number:
457-940-3
EC Name:
4-bromo-2,6-difluorobenzoic acid
Cas Number:
183065-68-1
Molecular formula:
Hill formula: C7H3BrF2O2 CAS formula: C7H3BrF2O2
IUPAC Name:
4-bromo-2,6-difluorobenzoic acid

Results and discussion

In vivo (LLNA)

Results
Parameter:
SI
Remarks on result:
other: The Stimulation indices were 0.7, 0.6, and 0.7 for the tested concentrations 25, 10, and 5 %, respectively.

Applicant's summary and conclusion

Interpretation of results:
not sensitising
Remarks:
Migrated information
Executive summary:

The skin sensitizing potential of 4-Bromo-2,6-difluorobenzoic acid was tested accroding to OECD 429. The Stimulation indices were 0.7, 0.6, and 0.7 for the tested concentrations 25, 10, and 5 %, respectively. Thus, 4-Bromo-2,6-difluorobenzoic acid is not considered as a skin sensitizer